- Home
- WGS vs WLYB Comparison
WGS vs WLYB Comparison
Compare WGS & WLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGS
- WLYB
- Stock Information
- Founded
- WGS 2017
- WLYB 1807
- Country
- WGS United States
- WLYB United States
- Employees
- WGS N/A
- WLYB N/A
- Industry
- WGS Retail: Computer Software & Peripheral Equipment
- WLYB Books
- Sector
- WGS Technology
- WLYB Consumer Discretionary
- Exchange
- WGS Nasdaq
- WLYB Nasdaq
- Market Cap
- WGS 2.4B
- WLYB 2.0B
- IPO Year
- WGS N/A
- WLYB N/A
- Fundamental
- Price
- WGS $121.67
- WLYB $39.94
- Analyst Decision
- WGS Strong Buy
- WLYB
- Analyst Count
- WGS 7
- WLYB 0
- Target Price
- WGS $99.29
- WLYB N/A
- AVG Volume (30 Days)
- WGS 988.8K
- WLYB 108.0
- Earning Date
- WGS 07-29-2025
- WLYB 09-04-2025
- Dividend Yield
- WGS N/A
- WLYB 3.46%
- EPS Growth
- WGS N/A
- WLYB N/A
- EPS
- WGS 0.05
- WLYB 1.53
- Revenue
- WGS $362,321,000.00
- WLYB $1,677,609,000.00
- Revenue This Year
- WGS $22.16
- WLYB $1.45
- Revenue Next Year
- WGS $19.63
- WLYB $2.70
- P/E Ratio
- WGS $2,540.29
- WLYB $24.78
- Revenue Growth
- WGS 48.70
- WLYB N/A
- 52 Week Low
- WGS $28.86
- WLYB $37.27
- 52 Week High
- WGS $123.11
- WLYB $52.90
- Technical
- Relative Strength Index (RSI)
- WGS 70.52
- WLYB 39.96
- Support Level
- WGS $102.97
- WLYB $41.30
- Resistance Level
- WGS $123.22
- WLYB $42.70
- Average True Range (ATR)
- WGS 6.99
- WLYB 0.00
- MACD
- WGS 1.96
- WLYB 0.09
- Stochastic Oscillator
- WGS 87.25
- WLYB 100.00
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
About WLYB John Wiley & Sons Inc.
John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.